GlassScriptPhysician profile
Harold D Schutte
NPI 1740201805
$39,783.89
in general payments reported to CMS, 2019-2025
11 companies · $1,853 in 2025
The $1,853 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,606 · 2020: $18K · 2021: $8,556 · 2022: $171 · 2023: $2,064 · 2024: $737 · 2025: $1,853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,893 · Food and Beverage: $1,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,893.14 |
| Food and Beverage | $1,761.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $15,946.99 | 2019-2020 | |
| Exactech, INC. | $15,110.20 | 2019-2023 | |
| Stryker Corporation | $4,686.83 | 2019-2025 | Mako, Aequalis Perform+, Aequalis Perform Reversed |
| Roche Diagnostics Corporation | $2,750.00 | 2020 | |
| Peerless Surgical INC. | $528.20 | 2024 | |
| Smith+Nephew, INC. | $367.02 | 2021 | |
| Depuy Synthes Sales INC. | $134.85 | 2023 | Na |
| Heron Therapeutics, INC. | $89.08 | 2024 | Zynrelef |
| Next Science LLC | $82.50 | 2022 | |
| Zimmer Biomet Holdings, INC. | $71.56 | 2025 | Juggerknotless Soft Anchor |
| Microport Orthopedics INC | $16.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Schutte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.